Cargando…
Theory and reality of antivirals against SARS-CoV-2
At present, over 180 million people have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide and there have been more than 3.8 million deaths due to the virus. However, specific effective antiviral treatment for this infectious disease is absent. At the beginnin...
Autores principales: | Zhao, Bo, Yang, Teng-Fei, Zheng, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362513/ https://www.ncbi.nlm.nih.gov/pubmed/34447813 http://dx.doi.org/10.12998/wjcc.v9.i23.6663 |
Ejemplares similares
-
Antiviral activity of medicinal plant-derived products against SARS-CoV-2
por: de Oliveira, Jonatas Rafael, et al.
Publicado: (2022) -
Updated Approaches against SARS-CoV-2
por: Li, Haiou, et al.
Publicado: (2020) -
Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020) -
Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19
por: Sun, Jin, et al.
Publicado: (2023) -
Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
por: Lee, Eunjin, et al.
Publicado: (2021)